IMU Biosciences
Immune Powered Precision Medicine
- Business Model
- B2B
- Website
- imubiosciences.com
- Total Funding
- $67.4M
- Last Round
- $53.0M Series AJun 2026
- Rounds
- 2
About
IMU Biosciences maps the immune system across health and disease to enable precision medicine diagnostics, monitoring, and therapeutics.
Summary
IMU Biosciences is a Biotech company. It has raised $67.4M in total across 2 rounds, most recently a $53.0M Series A round in Jun 2026. Investors include Molten Ventures, LifeX Ventures and K-Fund.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company